Deep dive into muscle repair yields new strategies to combat Duchenne muscular dystrophy

By A Mystery Man Writer

Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Sanford Burnham Prebys Medical Discovery Institute

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Muscular Dystrophy Treatment in India

PDF) Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy

Stem Cell Stories that Caught Our Eye: Killer Cells May Treat

Dystrophin The Stem Cellar

©2016-2024, reintegratieinactie.nl, Inc. or its affiliates